In The News

In The News

Washington Report | September 04, 2018
By: Kevin Hrusovsky
ALZFORUM.ORG | August 24, 2018
A lot can happen in a year.
Specialty Pharmacy Times | August 17, 2018
A new technology allows researchers to use brain biomarker neurofilament light chain (NfL) to uncover insights into the development and progression of neurological diseases, such as multiple sclerosis (MS).  
MD+DI | March 21, 2018
Quanterix teams up with DestiNA to develop assays to detect liver toxicity in patients.
Bloomberg | February 05, 2018
Bloomberg reporter Anne Mostue interviews Kevin Hrusovsky in segment called, "The Race to Diagnose CTE in the Living"

This website uses cookies. By continuing to use this website you are acknowledging and agree with our cookie policy.

AgreeLearn more